Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tenofovir Disoproxil Fumarate Formulations in Healthy Volunteers
NCT04671563Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Apr 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), Chronic Hepatitis B (CHB), sponsored by Yung Shin Pharmaceutical Industry. Started Apr 2019; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04671563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671563.